Help | RSS Feed

Oramed Pharmaceuticals, Inc. (NASD:ORMP) Seasonal Chart

Oramed Pharmaceuticals, Inc. (NASD:ORMP) Seasonality

ORMP Relative to the S&P 500
ORMP Relative to the S&P 500

ORMP Relative to the Sector
ORMP Relative to the Sector

Monthly Seasonal Oramed Pharmaceuticals, Inc. (NASD:ORMP)

Seasonal Chart Analysis

Analysis of the Oramed Pharmaceuticals, Inc. (NASD:ORMP) seasonal charts above shows that a Buy Date of December 22 and a Sell Date of April 24 has resulted in a geometric average return of 21.77% above the benchmark rate of the S&P 500 Total Return Index over the past 11 years. This seasonal timeframe has shown positive results compared to the benchmark in 9 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 11 years by an average of 30.92% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions,
including an orally ingestible insulin capsule or tablet.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore